Distinct neurochemical features of acute and persistent pain.
about
Decreased serotonin level during pregnancy alters morphological and functional characteristics of tonic nociceptive system in juvenile offspring of the ratRole of primary somatosensory cortex in the coding of painC2 domains of protein kinase C isoforms alpha, beta, and gamma: activation parameters and calcium stoichiometries of the membrane-bound statePeripheral metabotropic glutamate receptors as drug targets for pain relief.Metabotropic glutamate receptors: novel targets for pain relief.Emerging cell and molecular strategies for the study and treatment of painful peripheral neuropathies.Mas-related G-protein-coupled receptors inhibit pathological pain in mice.Increased morphine analgesia and reduced side effects in mice lacking the tac1 gene.The missing p in psychiatric training: why it is important to teach pain to psychiatrists.Nerve demyelination increases metabotropic glutamate receptor subtype 5 expression in peripheral painful mononeuropathy.Non-peptidergic small diameter primary afferents expressing VGluT2 project to lamina I of mouse spinal dorsal hornThe amygdala and persistent pain.Mechanical and heat hyperalgesia highly predict clinical pain intensity in patients with chronic musculoskeletal pain syndromes.Pain and suicidality: insights from reward and addiction neuroscience.MrgC agonism at central terminals of primary sensory neurons inhibits neuropathic painTemporal changes in MrgC expression after spinal nerve injury.Natural products evaluated in neuropathic pain models - a systematic review.Protein kinase C(alpha) is required for vanilloid receptor 1 activation. Evidence for multiple signaling pathways.What is the main mechanism of tramadol?Analgesic effect of a broad-spectrum dihydropyridine inhibitor of voltage-gated calcium channels.Role of tachykinins in the host response to murine gammaherpesvirus infection.A novel cell-cell signaling by microglial transmembrane TNFα with implications for neuropathic painAntinociceptive and anti-inflammatory properties of 7-hydroxycoumarin in experimental animal models: potential therapeutic for the control of inflammatory chronic pain.Profound reduction of somatic and visceral pain in mice by intrathecal administration of the anti-migraine drug, sumatriptanAnti-inflammatory, Antinociceptive, and Antioxidant Activities of Methanol and Aqueous Extracts of Anacyclus pyrethrum Roots.Possible implications of an accessory abductor digiti minimi muscle: a case report.Neuroplasticity induced by tooth pulp stimulation in trigeminal subnucleus oralis involves NMDA receptor mechanisms.Protein kinase C is involved in neurokinin receptor modulation of N- and L-type Ca2+ channels in DRG neurons of the adult rat.BDNF sensitizes the response of lamina II neurons to high threshold primary afferent inputs.Pain and somatic sensation are transiently normalized by illusory body ownership in a patient with spinal cord injury.Locally released small (non-protein) ninhydrin-reacting molecules underlie developmental differences of cultured medullary versus spinal dorsal horn neurons.Pharmacological Properties of Riparin IV in Models of Pain and Inflammation.
P2860
Q24798761-9AC2A76E-0463-484D-8820-9210C57A6E38Q26999219-BD2BDC50-3264-4E09-8FD8-F84CDF398B41Q28613889-8B02F81D-0A65-429C-872C-301A52FB08F5Q30722206-348A0CE4-91CC-4665-8969-C2861EA0BF6EQ33509127-0BCD1247-09A1-40D1-A1DD-1C1DBD9B1F29Q33975112-587714A9-0F24-49B5-8259-4969AA57D340Q34115658-1CACFB77-6978-47B6-A8F2-D940E9137E51Q34124840-592F9A1D-03D9-4F3B-87C7-E0AE1529D224Q34894116-384A87E4-DC45-4ED6-8CDB-48A6A5F69D80Q35380420-AF4C1FF8-3915-4EB9-8BEB-D571E17A3E53Q35690074-DF853BE0-9CF5-449F-9B38-AC4C213FAAA8Q35779153-A15905CD-7054-47CA-AFC5-D45619C81E31Q36637160-3DA5F1E2-6457-4A09-ABC3-F56B880703E5Q36786262-4FCFEA5C-8E77-44C5-A7DB-943FFAE10E0CQ37622078-6AE9BAE9-CEFE-4A78-883E-15C55B23FD2FQ37622877-3C3DAF7B-EB74-484B-83C1-75BEB2373AE0Q38164130-DDEA70B7-72AF-4146-9A59-F943E4A67CD4Q38287480-700CA22D-2E3D-4149-BA43-91DD6AC1E705Q38570329-642B63C8-5525-4F5D-AAF8-B9A8A7A28A5CQ38842798-790C1381-93E2-4624-B9E3-EBDEFA1F8FD7Q39604777-21F1B25E-0B25-4CC8-AA49-FB10AD8D9DACQ39683310-ED0C743C-3C82-4171-80F6-9F2AB62FED7AQ40358265-FE2D9CB7-BE92-4F30-8F8D-9FE7629C9D86Q40532425-1B1BDCBF-46DD-4AE5-99E6-9AC93D95888DQ41454364-5AFA2CE0-1EA6-4771-8FD8-8EB82D2121DEQ41895343-9D7590F9-E8C7-4DF8-A002-7DE6906E027AQ43607838-046D62C4-BA57-45DD-933E-8CB77416222FQ44378943-098450CF-28E6-44CF-8B74-385748010CA3Q44658118-D3DAD288-5858-46D3-B486-156ABEC4C86EQ48058155-10EEF37B-B773-487E-8228-A077B21F5E4AQ48501141-CC1EA5D8-5B17-414B-8705-11DBE1BB7F9DQ50992993-C2E123DA-02B0-4B0D-82FB-FBC907452EC1
P2860
Distinct neurochemical features of acute and persistent pain.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Distinct neurochemical features of acute and persistent pain.
@ast
Distinct neurochemical features of acute and persistent pain.
@en
type
label
Distinct neurochemical features of acute and persistent pain.
@ast
Distinct neurochemical features of acute and persistent pain.
@en
prefLabel
Distinct neurochemical features of acute and persistent pain.
@ast
Distinct neurochemical features of acute and persistent pain.
@en
P2860
P356
P1476
Distinct neurochemical features of acute and persistent pain.
@en
P2093
A I Basbaum
P2860
P304
P356
10.1073/PNAS.96.14.7739
P407
P577
1999-07-01T00:00:00Z